 |
|
| Blog results | Results 1 - 10 of about 433 for salmeterol smart. (0.16 seconds) |
| Sorted by relevance Sort by date |
| 25 Nov 2009 by charterror Bousquet J, Miravitlles M and Wiren A; Budesonide/formoterol provides better efficacy at a debase or similar outlay as compared to high-dose salmeterol/fluticasone treatment. Abstract presented at ERS 2007. * Symbicort SMART is a trade ... Chart error - http://charterror.higgsino.com/ |
| 7 Nov 2007 by Rubén Roa Estudio SMART: salmeterol y asma A Comparison of Usual Pharmacotherapy for Asthma or Usual Pharmacotherapy Plus Salmeterol Harold S. Nelson, MD; Scott T. Weiss, MD, MS; Eugene R. Bleecker, MD; Steven W. Yancey, MS; Paul M. Dorinsky, MD; ... Atencion Primaria - http://atencionprimaria.wordpress.com/ [ More results from Atencion Primaria ] |
| 24 Jun 2008 by bowersc The Salmeterol Multicenter Asthma Research Trial (SMART) and a subsequent meta-analysis of randomised controlled trials (see NPCi blog 53) raised concerns about the safety of LABAs in asthma, in view of the apparent increased incidence ... NPCi blog - http://www.npci.org.uk/blog/ - References [ More results from NPCi blog ] |
| 14 Jun 2006 The FDA notes that the SMART and Salmeterol Nationwide Surveillance studies were conducted in asthma patients; no studies have been performed to determine adequately whether the rate of death in patients with chronic obstructive ... Medscape Today Headlines - http://www.medscape.com/medscapetoday |
| 9 Sep 2008 El estudio SMART (Salmeterol Multicenter Asthma Research Trial) se detuvo debido a que los datos iniciales sugerían que el uso de salmeterol se asociaba con un aumento de la gravedad de los episodios de asma5. ... Atención Primaria - http://www.elsevier.es/ap/ |
| 1 Oct 2003 The interim results of a study of approximately 29000 asthma patients in the Salmeterol Multi-Center Asthma Research Trial (SMART) showed more asthma-related deaths and life-threatening asthmatic episodes among African American patients ... Yourlawyer.com (Foradil News) - http://www.yourlawyer.com/topics/overview/Foradil |
| 3 Jun 2008 ‡Estimate of the number of additional asthma-related deaths in patients treated with salmeterol in SMART, assuming 10000 patients received salmeterol for a 28-week treatment period.Estimate calculated as the difference between the ... RxList - News and Features - http://www.rxlist.com/script/main/hp.asp - References [ More results from RxList - News and Features ] |
| 25 Jun 2007 In addition to reviewing the results of the Surveillance study in the United Kingdom and the Salmeterol Multicenter Asthma Research Trial (SMART) in the United States, the study author included data on formoterol (FM) provided to the ... Medscape Pediatrics Headlines - http://www.medscape.com/pediatrics - References |
| 1 Oct 2009 The results of the Salmeterol Multicenter Asthma Research Trial (SMART study), however, in which addition of a long-acting β-agonist to "usual therapy" resulted in an increased risk of fatal and near-fatal asthmatic attacks compared ... Survey of Anesthesiology - Current Issue - http://journals.lww.com/surveyanesthesiology/pages/cur... |
| 19 Apr 2007 Similarly, SMART reported on a very large study of asthmatics > 12 years of age who received the usual care plus salmeterol (n = 13176) vs placebo (n = 13179) for 28 weeks. The combined endpoint of respiratory-related deaths or ... Medscape Nurses Headlines - http://www.medscape.com/nurses |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
